FDA
-
-
-
-
-
-
-
KORU Medical Systems Announces First Quarter 2026 Results
-
-
-
-
-
-
-
KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
-
-
-
-
-
-
-
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
-
-
-
-
-
-
-
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
-
-
-
-
-
-
-
KORU Medical names Adam Kalbermatten as chief commercial officer
-
-
-
-
-
-
-
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
-
-
-
-
-
-
-
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter
-
335,206 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


